Literature DB >> 24198049

Treatment and impact of dyslipidemia in diabetic nephropathy.

Tadashi Toyama1, Miho Shimizu, Kengo Furuichi, Shuichi Kaneko, Takashi Wada.   

Abstract

Recent epidemiological research revealed that dyslipidemia is a risk factor for development and progression of diabetic nephropathy. Results from interventional studies revealed the possibility that anti-hyperlipidemic agents have a better effect on diabetic nephropathy through improvement of albuminuria and loss of renal function. In addition, dyslipidemia may be a consequence of albuminuria and renal dysfunction, thereby perpetuating kidney damage. Today, the proportion of diabetic patients receiving statins is increasing due to their beneficial effect on cardiovascular mortality. However, treatment for patients should be determined based on consideration of the risk and benefit of the treatment. More insight into the pathogenesis of diabetic nephropathy and the effects of life-style changes is required.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24198049     DOI： 10.1007/s10157-013-0898-1

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN： 1342-1751            Impact factor:   2.801


  45 in total

1.  The safety of rosuvastatin as used in common clinical practice: a postmarketing analysis.

Authors:  Alawi A Alsheikh-Ali; Marietta S Ambrose; Jeffrey T Kuvin; Richard H Karas
Journal:  Circulation       Date:  2005-05-23       Impact factor: 29.690

Review 2.  The RAAS in the pathogenesis and treatment of diabetic nephropathy.

Authors:  Piero Ruggenenti; Paolo Cravedi; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2010-05-04       Impact factor: 28.314

3.  Predictors of incident albuminuria in the Framingham Offspring cohort.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Ashish Upadhyay; James B Meigs; Caroline S Fox
Journal:  Am J Kidney Dis       Date:  2010-11       Impact factor: 8.860

4.  Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.

Authors:  T Yamamoto; T Nakamura; N A Noble; E Ruoslahti; W A Border
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

5.  Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats.

Authors:  A Kuwabara; M Satoh; N Tomita; T Sasaki; N Kashihara
Journal:  Diabetologia       Date:  2010-06-06       Impact factor: 10.122

6.  Pleiotropic effects of atorvastatin and fenofibrate in metabolic syndrome and different types of pre-diabetes.

Authors:  Robert Krysiak; Anna Gdula-Dymek; Ryszard Bachowski; Boguslaw Okopien
Journal:  Diabetes Care       Date:  2010-06-29       Impact factor: 19.112

7.  Statins, risk of diabetes, and implications on outcomes in the general population.

Authors:  Kang-Ling Wang; Chia-Jen Liu; Tze-Fan Chao; Chi-Ming Huang; Cheng-Hsueh Wu; Su-Jung Chen; Tzeng-Ji Chen; Shing-Jong Lin; Chern-En Chiang
Journal:  J Am Coll Cardiol       Date:  2012-08-08       Impact factor: 24.094

8.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Authors:  Y Ohkubo; H Kishikawa; E Araki; T Miyata; S Isami; S Motoyoshi; Y Kojima; N Furuyoshi; M Shichiri
Journal:  Diabetes Res Clin Pract       Date:  1995-05       Impact factor: 5.602

9.  Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).

Authors:  Helen M Colhoun; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew W Neil; Shona J Livingstone; Valentine Charlton-Menys; David A DeMicco; John H Fuller
Journal:  Am J Kidney Dis       Date:  2009-06-21       Impact factor: 8.860

10.  Long-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy.

Authors:  Miho Shimizu; Kengo Furuichi; Tadashi Toyama; Shinji Kitajima; Akinori Hara; Kiyoki Kitagawa; Yasunori Iwata; Norihiko Sakai; Toshinari Takamura; Mitsuhiro Yoshimura; Hitoshi Yokoyama; Shuichi Kaneko; Takashi Wada
Journal:  Diabetes Care       Date:  2013-10-02       Impact factor: 19.112
View more
  11 in total

1.  Rationale and study design of a clinical trial to assess the effects of LDL apheresis on proteinuria in diabetic patients with severe proteinuria and dyslipidemia.

Authors:  Takashi Wada; Eri Muso; Shoichi Maruyama; Akinori Hara; Kengo Furuichi; Kenichi Yoshimura; Mariko Miyazaki; Eiichi Sato; Masanori Abe; Yugo Shibagaki; Ichiei Narita; Hitoshi Yokoyama; Noriko Mori; Yukio Yuzawa; Takeshi Matsubara; Tatsuo Tsukamoto; Jun Wada; Takafumi Ito; Kosuke Masutani; Kazuhiko Tsuruya; Shoichi Fujimoto; Akihiro Tsuda; Hitoshi Suzuki; Kenji Kasuno; Yoshio Terada; Takeshi Nakata; Noriaki Iino; Shuzo Kobayashi
Journal:  Clin Exp Nephrol       Date:  2017-10-27       Impact factor: 2.801

2.  Albuminuria and hypertension: the chicken or the egg?

Authors:  Yasuyuki Nagasawa; Yukiko Hasuike; Masayoshi Nanami; Takahiro Kuragano; Takeshi Nakanishi
Journal:  Hypertens Res       Date:  2014-09-04       Impact factor: 3.872

3.  Higher Serum Asprosin Level is Associated with Urinary Albumin Excretion and Renal Function in Type 2 Diabetes.

Authors:  Xia Deng; Li Zhao; Chang Guo; Ling Yang; Dong Wang; Yanyan Li; Hong Xia; Chenxi Wang; Zhensheng Cai; Lian Li; Zhicong Zhao; Guoyue Yuan
Journal:  Diabetes Metab Syndr Obes       Date:  2020-11-13       Impact factor: 3.168

4.  The role of statins in patients with early diabetic nephropathy: A protocol for systematic review and meta-analysis.

Authors:  Xi Zhao; Shu Chun Zhou; Xiu Fang Wang; Hong Wu Liao
Journal:  Medicine (Baltimore)       Date:  2022-06-17       Impact factor: 1.817

Review 5.  Potential of Dietary Non-Provitamin A Carotenoids in the Prevention and Treatment of Diabetic Microvascular Complications.

Authors:  Ana Gabriela Murillo; Maria Luz Fernandez
Journal:  Adv Nutr       Date:  2016-01-15       Impact factor: 8.701

6.  Relationship between dyslipidemia and albuminuria in prediabetic adults: the Korea National Health and Nutrition Examination Survey 2011-2012.

Authors:  Ga Eun Nam; Kyungdo Han; Do Hoon Kim; Yong Gyu Park; Yeo Joon Yoon; Young Eun Kim; Sangsu Lee; Sungho Lee; Yong Kyun Roh
Journal:  Endocrine       Date:  2014-09-10       Impact factor: 3.633

Review 7.  Improvements in the Management of Diabetic Nephropathy.

Authors:  Evangelia Dounousi; Anila Duni; Konstantinos Leivaditis; Vasilios Vaios; Theodoros Eleftheriadis; Vassilios Liakopoulos
Journal:  Rev Diabet Stud       Date:  2015-08-10

8.  NLRX1 does not play a role in diabetes nor the development of diabetic nephropathy induced by multiple low doses of streptozotocin.

Authors:  Angelique M L Scantlebery; Melissa Uil; Loes M Butter; Renée Poelman; Nike Claessen; Stephen E Girardin; Sandrine Florquin; Joris J T H Roelofs; Jaklien C Leemans
Journal:  PLoS One       Date:  2019-03-25       Impact factor: 3.240

9.  Effect of edaravone in diabetes mellitus-induced nephropathy in rats.

Authors:  Rajavel Varatharajan; Li Xin Lim; Kelly Tan; Chai Sze Tay; Yi Leng Teoh; Shaikh Sohrab Akhtar; Mani Rupeshkumar; Ivy Chung; Nor Azizan Abdullah; Urmila Banik; Sokkalingam A Dhanaraj; Pitchai Balakumar
Journal:  Korean J Physiol Pharmacol       Date:  2016-06-23       Impact factor: 2.016

10.  Spatholobus suberectus Ameliorates Diabetes-Induced Renal Damage by Suppressing Advanced Glycation End Products in db/db Mice.

Authors:  Moon Ho Do; Jinyoung Hur; Jiwon Choi; Yoonsook Kim; Ho-Young Park; Sang Keun Ha
Journal:  Int J Mol Sci       Date:  2018-09-14       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.